Shreesha Khandige1, Smitha Rao2
INTRODUCTION Cervical cancer is the third most common female malignancies worldwide.1 Cervical screening is the process of detecting abnormal changes in the cervix before they can develop into cervical cancer. Conventional cervical smear has reduced mortality from cervical cancer considerably, but the problem is it has sensitivity of only 51% and false negative rate of 5-10%. The histopathological study where a small piece of the cervical tissue is obtained either by a cone biopsy or by any other means has a very high sensitivity. Ninety patients were chosen aged between 25 and 65 years. Comparison of cytological findings with histological counterpart was done considering histology as the gold standard.
We concluded that in a developing country like ours the cervical smear is a cost effective way of screening the patients.
